Tocqueville Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History

Tocqueville Asset Management’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-181,500	Closed	-$744K	–	725
2022 Q1	$744K	Hold	181,500	–	–	0.01%	467
2021 Q4	$648K	Sell	181,500 -425,000	-70%	-$1.49M	0.01%	517
2021 Q3	$2.21M	Buy	606,500 +430,000	+244%	+$1.74M	0.03%	352
2021 Q2	$770K	Buy	176,500 +100,000	+131%	+$407K	0.01%	482
2021 Q1	$314K	Hold	76,500	–	–	﹤0.01%	637
2020 Q4	$305K	Buy	+76,500	New	+$247K	0.01%	619

Other funds holding ATRS

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Tocqueville Asset Management's ATRS Position: Q2 2022 in Review

Tocqueville Asset Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 181,500 shares — an estimated $744K sold.

Tocqueville Asset Management first reported a position in ATRS in Q4 2020 and held it in 6 quarters. The position peaked at $2.21M in Q3 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Tocqueville Asset Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Tocqueville Asset Management sold 181,500 Antares Pharma, Inc. shares in Q2 2022, an estimated $744K.
Tocqueville Asset Management first reported a position in Antares Pharma, Inc. in Q4 2020 and held it in 6 quarters.
Tocqueville Asset Management's Antares Pharma, Inc. position peaked at $2.21M in Q3 2021.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Tocqueville Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.